`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE SOUTHERN DISTRICT OF NEW YORK
`
`
`DEFENDANT MYLAN INC.’S
`SUPPLEMENTAL RULE 7.1
`DISCLOSURE STATEMENT
`
`
`
`
`
`
`
`
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
` Civil Action No. 14-cv-2647-PAC
` ECF Case
`
`Kowa Company, Ltd.,
`Kowa Pharmaceuticals America, Inc., and
`Nissan Chemical Industries, Ltd.,
`
`
`
`
`
` Plaintiffs,
`
`v.
`
`
`
`
`
`
`
`
`
`
`Mylan, Inc., and
`Mylan Pharmaceuticals, Inc.,
`
` Defendants.
`
`
`
`Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, Defendant Mylan Inc.
`
`hereby states that (i) it is indirectly wholly owned by Mylan N.V., a publicly-held company; and
`
`(ii) Abbott Laboratories, a publicly-held company, owns more than 10% of Mylan N.V.’s stock
`
`through wholly-owned subsidiaries.
`
`Respectfully submitted,
`
`SAIBER LLC
`
`Attorneys for Defendants
`Mylan Pharmaceuticals Inc. and Mylan Inc.
`
`
`By: s/ Jakob B. Halpern
`Arnold B. Calmann (acalmann@saiber.com)
`Jakob B. Halpern (jbh@saiber.com)
`One Gateway Center, Suite 1000
`Newark, New Jersey 07102
`(973) 622-3333 (telephone)
`(973) 622-3349 (facsimile)
`
`
`
`
`
`
`
`
`
`
`
`NCI Exhibit 2014
`Page 1 of 4
`
`
`
`Case 1:14-cv-02647-PAC Document 82 Filed 05/15/15 Page 2 of 2
`
`
`
`Dated: May 15, 2015
`
`
`Of Counsel
`William A. Rakoczy (wrakoczy@rmmslegal.com)
`Deanne M. Mazzochi (dmazzochi@rmmslegal.com)
`Amy D. Brody (abrody@rmmslegal.com)
`Luke T. Shannon (lshannon@rmmslegal.com)
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`(312) 222-6301 (telephone)
`(312) 222-6321 (facsimile)
`
`
`
`
`
`
`2
`
`NCI Exhibit 2014
`Page 2 of 4
`
`
`
`Case 1:14-cv-02647-PAC Document 83 Filed 05/15/15 Page 1 of 2
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE SOUTHERN DISTRICT OF NEW YORK
`
`
`DEFENDANT MYLAN
`PHARMACEUTICALS INC.’S
`SUPPLEMENTAL RULE 7.1
`DISCLOSURE STATEMENT
`
`
`
`
`
`
`
`
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
` Civil Action No. 14-cv-2647-PAC
` ECF Case
`
`Kowa Company, Ltd.,
`Kowa Pharmaceuticals America, Inc., and
`Nissan Chemical Industries, Ltd.,
`
`
`
`
`
` Plaintiffs,
`
`v.
`
`
`
`
`
`
`
`
`
`
`Mylan, Inc., and
`Mylan Pharmaceuticals, Inc.,
`
` Defendants.
`
`
`
`Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, Defendant Mylan
`
`Pharmaceuticals Inc. hereby states that (i) it is a wholly-owned subsidiary of Mylan Inc., which
`
`is indirectly wholly owned by Mylan N.V., a publicly-held company; and (ii) Abbott
`
`Laboratories, a publicly-held company owns more than 10% of Mylan N.V.’s stock through
`
`wholly-owned subsidiaries.
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`SAIBER LLC
`
`Attorneys for Defendants
`Mylan Pharmaceuticals Inc. and Mylan Inc.
`
`
`By: s/ Jakob B. Halpern
`Arnold B. Calmann (acalmann@saiber.com)
`Jakob B. Halpern (jbh@saiber.com)
`One Gateway Center, Suite 1000
`Newark, New Jersey 07102
`(973) 622-3333 (telephone)
`(973) 622-3349 (facsimile)
`
`
`NCI Exhibit 2014
`Page 3 of 4
`
`
`
`Case 1:14-cv-02647-PAC Document 83 Filed 05/15/15 Page 2 of 2
`
`
`
`Dated: May 15, 2015
`
`
`Of Counsel
`William A. Rakoczy (wrakoczy@rmmslegal.com)
`Deanne M. Mazzochi (dmazzochi@rmmslegal.com)
`Amy D. Brody (abrody@rmmslegal.com)
`Luke T. Shannon (lshannon@rmmslegal.com)
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`(312) 222-6301 (telephone)
`(312) 222-6321 (facsimile)
`
`
`
`
`
`
`2
`
`NCI Exhibit 2014
`Page 4 of 4